Size | Price | Stock | Qty |
---|---|---|---|
250mg |
|
||
500mg |
|
||
Other Sizes |
|
ln Vitro |
In neural stem cells (NSCs), glufosinate (1-100 μM; 12DIV) destroys intercellular traces of secreted V-SVZ [2]. Celsr2 gene RT-PCR at 100 μM is significantly decreased by glufosinate (1-100 μM; 12DIV) [2].
|
---|---|
ln Vivo |
The maternal toxicity of 50 or 250 mg/kg of glufosinate (10-250 mg/kg; gavage; daily; on days 6–15 of gestation) was observed in Wistar rats [3]. In female musk deer, the half-life is shorter than 4 hours [3].
|
Cell Assay |
RT-PCR [2]
Cell Types: Ependymal cells Tested Concentrations: 1, 3, 10, 100 μM Incubation Duration: 12DIV (NSCs -to) expression[2]. -Ependymal cell time point) Experimental Results: Celsr2 gene expression was Dramatically diminished at 100 μM. |
ADME/Pharmacokinetics |
Metabolism / Metabolites
The principal metabolite in urine & feces is 3-[hydroxy(methyl)phosphinoyl]propionic acid. In plants, degradation of glufosinate-ammonium involves deamination, decarboxylation, & finally beta-oxidation to carbon dioxide. Biological Half-Life ...A 65-yr-old male ingested BASTA, which contains 20% w/v of glufosinate ammonium... The changes in serum glufosinate concn exhibited T-1/2 alpha of 1.84 and T-1/2 beta of 9.59 hr. /BASTA/ |
Toxicity/Toxicokinetics |
Toxicity Summary
Glufosinate irreversibly inhibits the enzyme glutamine synthetase, which decreases ammonia detoxification. Increased ammonia levels lead to impairment of photorespiration and photosynthesis in plants. (T10) Toxicity Data LC50 (rat) = 1,260 mg/m3 Non-Human Toxicity Values LD50 Rat (male) oral 2000 mg/kg LD50 Rat (female) oral 1620 mg/kg LD50 Mouse (male) oral 431 mg/kg LD50 Mouse (female) oral 416 mg/kg For more Non-Human Toxicity Values (Complete) data for GLUFOSINATE-AMMONIUM (11 total), please visit the HSDB record page. |
References |
|
Additional Infomation |
2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid is a non-proteinogenic alpha-amino acid that is 2-aminobutanoic acid which is substituted at position 4 by a hydroxy(methyl)phosphoryl group. It is a member of phosphinic acids and a non-proteinogenic alpha-amino acid.
Glufosinate is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Glufosinate has been reported in Streptomyces hygroscopicus and Streptomyces viridochromogenes with data available. Glufosinate or its ammonium salt DL-phosphinothricin is an active ingredient in several nonselective systemic herbicides such as Basta, Rely, Finale, Ignite, Challenge, and Liberty. It interferes with the glutamine biosynthetic pathway that binds to the glutamate site of the enzyme. Glufosinate-treated plants die due to a buildup of ammonia and a cessation of photosynthesis due to lack of glutamine. Mechanism of Action ...Glufosinate ammonium is a structural analogue of glutamate & acts in plants by inhibition of glutamine synthetase leading to a complete breakdown of ammonia metab. Owing to the structural analogy of glufosinate ammonium to glutamate, its effect on various glutamate-utilizing systems needed to be investigated in mammals. Although in laboratory animals glufosinate ammonium causes an inhibition of glutamine synthetase activity in different tissues, this inhibition led to slight increases of glutamate and ammonia levels at high sublethal and lethal doses only. After oral admin for 28 days, glufosinate ammonium had no effect on glutathione & carbohydrate metab & no effect on biosynthesis of non-essential amino acids in rats & dogs. Glufosinate ammonium does not interfere with various neurotransmitter receptors in vitro & does not influence the catecholamine neurotransmitter tissue concn after iv application. The results of these studies show that ... in mammals the inhibition of glutamine synthetase activity in various tissues does not lead to a breakdown of ammonia metab. The mammalian metab ... compensates for this inhibition of glutamine synthetase activity by various other metabolic pathways ... |
Molecular Formula |
C5H15N2O4P
|
---|---|
Molecular Weight |
198.15
|
Exact Mass |
215.103
|
CAS # |
77182-82-2
|
Related CAS # |
Glufosinate;51276-47-2
|
PubChem CID |
4794
|
Appearance |
White to off-white solid powder
|
Boiling Point |
519.1ºC at 760 mmHg
|
Melting Point |
210°C
|
Flash Point |
100 °C
|
LogP |
0.244
|
Hydrogen Bond Donor Count |
3
|
Hydrogen Bond Acceptor Count |
5
|
Rotatable Bond Count |
4
|
Heavy Atom Count |
11
|
Complexity |
193
|
Defined Atom Stereocenter Count |
0
|
InChi Key |
IAJOBQBIJHVGMQ-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C5H12NO4P/c1-11(9,10)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)(H,9,10)
|
Chemical Name |
2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid
|
Synonyms |
HOE-00661; HOE 00661; Glufosinate-ammonium
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O : ~250 mg/mL (~1261.61 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (504.64 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 5.0467 mL | 25.2334 mL | 50.4668 mL | |
5 mM | 1.0093 mL | 5.0467 mL | 10.0934 mL | |
10 mM | 0.5047 mL | 2.5233 mL | 5.0467 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.